Schott Pharma AG KGaA (WBO:1SXP) FFO


WBO:1SXP Schott Pharma AG & CO KGaA WBO:1SXP
60 GF Score
Price €17.32
GF Value €28.09
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Schott Pharma AG KGaA FFO?

FFO (Funds from operations) only applies to REITs.

WBO:1SXP
60GF Score
Schott Pharma AG & CO KGaA WBO:1SXP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Schott Pharma AG KGaA (WBO:1SXP) Overvalued in 2026?

Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued. The current stock price of €17.32 is trading 38.3% below its estimated GF Value™ of €28.09. GuruFocus considers Schott Pharma AG KGaA to be Significantly Undervalued.

Key valuation signals for WBO:1SXP:

  • FFO:
  • GF Value™: €28.09 vs. price of €17.32 (38.3% below fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the WBO:1SXP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Schott Pharma AG KGaA Business Description

Other Exchanges 1SXP:Italy1SXP:Germany
Address Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
60GF Score

Get the complete analysis for WBO:1SXP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.32
Price
€28.09
GF Value